SPRY4 and ovarian cancer: Overexpression of SPRY4-IT1 promoted EMT via the regulation of E-cadherin and vimentin expression in NSCLC cells [24], ESCC cells [26, 27], colorectal cancer [18, 28], and ovarian cancer cells [29].